MOONRAY-01, A Study of LY3962673 in Participants With KRAS G12D-Mutant Solid Tumors

Clinical trial NCT06586515 · RECRUITING

Trial details

NCT number: NCT06586515
Sponsor: Eli Lilly and Company
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Pancreatic Ductal Adenocarcinoma Non-small Cell Lung Cancer Colorectal Cancer

Start date: 2024-09-12
Primary completion: 2029-03-01
Enrollment: 630

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.